期刊文献+

白念珠菌MRR2基因错义突变C1409A与氟康唑耐药的相关性 被引量:2

Correlation between C1409A missense mutation in MRR2 gene and fluconazole resistance of Candida albicans
下载PDF
导出
摘要 目的研究锌簇转录因子——多药耐药调节因子2(Mrr2)编码基因MRR2错义突变C1409A与白念珠菌氟康唑耐药的相关性。方法利用白念珠菌工程菌株SN152构建MRR2基因敲除菌株,通过一步法克隆及定点突变技术构建MRR2基因C1409A突变型表达质粒,再用高效醋酸锂转染法将质粒片段转染入MRR2基因敲除菌株,异位表达于ADE2位点以构建MRR2基因定点突变菌株。通过体外药物敏感性试验及实时荧光定量聚合酶链反应(PCR)分析错义突变C1409A与氟康唑耐药的关系。结果氟康唑对MRR2基因C1409A定点突变的白念珠菌的最低抑菌浓度(MIC)较对工程菌株SN152的MIC增加4倍,CDR1表达上调约3倍。结论 MRR2基因错义突变C1409A可上调白念珠菌CDR1表达并介导白念珠菌对氟康唑的耐药。 ObjectiveTo study the correlation between C1409A missense mutation in MRR2 gene [the gene encoding zinc cluster transcription factor-multidrug resistance regulator 2(Mrr2)] and fluconazole resistance of Candida albicans. MethodsThe isolates of Candida albicans containing C1409A missense mutation in MRR2 gene were generated by one-step cloning technology and site-directed mutagenesis based on MRR2Δ/Δ mutant,which was recombined from Candida albicans engineering isolate SN152. The mutated MRR2 gene was expressed at ADE2 locus using classical lithium acetate transfection method. Fluconazole susceptibility test and real-time fluorescence quantitation polymerase chain reaction (PCR) were performed to analyze the correlation between C1409A missense mutation in MRR2 gene and fluconazole resistance. ResultsThe recombinant isolates contributed to an almost 3-time increase for CDR1 expression and a 4-time increase for minimal inhibitory concentration(MIC) in fluconazole resistance compared with SN152. ConclusionsThe C1409A missense mutation in MRR2 gene contributes to fluconazole resistance of Candida albicans with upregulating CDR1 expression.
出处 《检验医学》 CAS 2016年第9期744-749,共6页 Laboratory Medicine
基金 黄浦区卫生局项目(2012-HGG-44) 上海市自然科学基金项目(15ZR1426900)
关键词 白念珠菌 氟康唑 耐药 MRR2基因 错义突变 Candida albicans Fluconazole Drug resistance MRR2 gene Missense mutation
  • 相关文献

参考文献19

  • 1XIANG MJ,LIU JY,NI PH, Ergll mutationsassociated with azole resistance in clinical isolates ofCandida albicans[J]. FEMS Yeast Res,2013,13(4):386-393.
  • 2DUNKEL N,BLASS J,ROGERS PD,et al.Mutations in the multi-drug resistance regulatorMRR1,followed by loss of heterozygosity, are themain cause of MDR1 overexpression in fluconazoleresistantCandida albicans strains[J]. Mol Microbiol,2008,69(4):827-840.
  • 3FLOWERS SA,BARKER KS,BERKOW EL,et al. Gain-of-function mutations in UPC2 are afrequent cause of ERG11 upregulation in azoleresistantclinical isolates of Candida albicans[J].Eukaryot Cell,2012,11(10):1289-1299.
  • 4COSTE A,TURNER V,ISCHER F,et al. Amutation in Tac1p,a transcription factor regulatingCDR1 and CDR2,i s coupl ed wi th los s ofheterozygosity at chromosome 5 to mediate antifungalresistance in Candida albicans[J]. Genetics,2006,172(4):2139-2156.
  • 5EDDOUZI J,PARKER JE,VALE-SILVA LA,et al. Molecular mechanisms of drug resistance inclinical Candida species isolated from Tunisianhospitals[J]. Antimicrob Agents Chemother,2013,57(7):3182-3193.
  • 6GULATI M,NOBILE CJ. Candida albicansbiofilms:development,regulation,and molecularmechanisms[J]. Microbes Infect,2016,18(5):310-321.
  • 7LI L,AN M, SHEN H, e t a l . Th e n o n -Geldanamycin Hsp90 inhibitors enhanced theantifungal activity of fluconazole[J]. Am J TranslRes,2015,7(12):2589-2602.
  • 8KALKANDELEN KT,DOLUCA DERELI M.Investigation of mutations in transcription factors ofefflux pump genes in fluconazole-resistant Candidaalbicans strains overexpressing the efflux pumps[J].Mikrobiyol Bul,2015,49(4):609-618.
  • 9COSTE A,SELMECKI A,FORCHE A,et al.Genotypic evolution of azole resistance mechanismsin sequential Candida albicans isolates[J]. Eukaryot Cell,2007,6(10):1889-1904.
  • 10COSTE AT,CRITTIN J,BAUSER C,et al.Functional analysis of cis- and trans-acting elementsof the Candida albicans CDR2 promoter with a novelpromoter reporter system[J]. Eukaryot Cell,2009,8(8):1250-1267.

二级参考文献13

  • 1Coste AT, Karababa M, Ischer F, et al. TACI, transcrip-tional activator of CDR genes, is a new transcription fac- tor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2[J]. Eukaryot Cell,2004,3(6): 1639-1652.
  • 2Morschhauser J, Barker KS, Liu TF, et al. The transcrip- tion factor Mrrlp controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albi- cans[J]. PLoS Pathog,2007,3(11):e164.
  • 3Silver PM, Oliver BG, White TC. Role of Candida albi- cans transcription factor Upc2p in drug resistance and sterol metabolism[J]. Eukaryot Cell,2004,3(6):1391-1397.
  • 4Schillig R, Morschhauser J. Analysis of a fungus-specific transcription factor family, the Candida albicans zinc cluster proteins, by artificial activation[J]. Mol Microbiol, 2013,89(5):1003-1017.
  • 5Noble SM, Johnson AD. Strains and strategies for large- scale gene deletion studies of the diploid human fungal pathogen Candida albicans [J]. Eukaryot Cell,2005,4(2): 298-309.
  • 6Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans[J]. Genetics,1993,134(3): 717-728.
  • 7Staab JF, Sundstrom P. URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes[J]. Trends Microbiol,2003,11(2):69-73.
  • 8Brand A, MacCallum DM, Brown A J, et al. Ectopic ex-pression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus[J]. Eukaryot Cell,2004,3 (4):900-909.
  • 9Cheng S, Nguyen MH, Zhang Z, et al. Evaluation of the roles of four Candida albicans genes in virulence by usi- ng gene disruption strains that express URA3 from the native locus[J]. Infect Immun,2003,71(10):6101-6103.
  • 10Wilson RB, Davis D, Mitchell AP. Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions[J]. J Bacteriol, 1999,181 (6): 1868-1874.

共引文献6

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部